A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
for Psychosis Associated With Alzheimer's Disease
Sites in Dayton, Independence +32 more locations
Sponsor: MapLight Therapeutics
Sex: All·Age: 55 - 90
Code: NCT06887192·Phase 2·Recruiting·Listed Mar 2025